What does SB MEDICAL do?

SB MEDICAL is a general practice in Brussel. Private Limited, started on 23 June 2020, 2 establishments.

What is the address of SB MEDICAL?

The registered office of SB MEDICAL is located at Jacques de Lalaingstraat 18, 1040 Brussel.

Is SB MEDICAL still active?

Yes. According to the CBE (18 September 2026) SB MEDICAL is active, legal situation “Normale toestand”, started on 23 June 2020.

Is SB MEDICAL registered on Peppol?

Yes, SB MEDICAL is registered on the Peppol network with ID 0208:0748860883.

What is the enterprise number of SB MEDICAL?

The enterprise number of SB MEDICAL is BE0748860883.

When was SB MEDICAL founded?

SB MEDICAL was founded on 23 June 2020.

Who are the directors of SB MEDICAL?

According to the 2024 annual accounts, the directors of SB MEDICAL are: SHAKE BAKHSHYAN.

Is SB MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 June 2020; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did SB MEDICAL make in 2024?

SB MEDICAL recorded a loss after taxes of € 10,374 in financial year 2024.

What is the revenue of SB MEDICAL?

As a small company, SB MEDICAL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 41,742.

SB MEDICAL (Private Limited) - Brussel - BE0748860883

Dossier SB MEDICAL, printed on 18 September 2026 from databakkes.be/en/0748860883/sb-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 3 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2023 and 2024.

Financials

Financial year 2024

SB MEDICAL from Brussel, company number BE0748860883, closed financial year 2024 with a result of € -10,374 after tax. For that financial year SB MEDICAL recorded a gross margin of € 41,742 and equity of € -16,570. Compared with financial year 2023, the result moved from € -8,650 to € -10,374. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on November 14, 2025.

What it is worth Caution

€ -16,570

▼ € 10,374 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -10,374

▼ 20 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 594

▲ 38% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -22,570.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 176,526

▼ 15% vs 2023

€ 34,880 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 12,150

▲ 45% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 744

▼ 28% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 20,050 Gross margin 2021: € 20,050 First fiscal year in the series	€ 78,142 Gross margin 2022: € 78,142 ▲ 290% vs 2021 (€ 20,050) Favourable step	€ 46,940 Gross margin 2023: € 46,940 ▼ 40% vs 2022 (€ 78,142) Unfavourable step	€ 41,742 Gross margin 2024: € 41,742 ▼ 11% vs 2023 (€ 46,940) Unfavourable step	▼ 11%
Profit after taxes	€ -25,652 Profit after taxes 2021: € -25,652 First fiscal year in the series	€ 22,107 Profit after taxes 2022: € 22,107 ▲ € 47,759 vs 2021 (€ -25,652) Favourable step	€ -8,650 Profit after taxes 2023: € -8,650 ▼ € 30,757 vs 2022 (€ 22,107) Unfavourable step	€ -10,374 Profit after taxes 2024: € -10,374 ▼ € 1,724 vs 2023 (€ -8,650) Unfavourable step	▼ € 1,724
Equity	€ -19,652 Equity 2021: € -19,652 First fiscal year in the series	€ 2,454 Equity 2022: € 2,454 ▲ € 22,107 vs 2021 (€ -19,652) Favourable step	€ -6,196 Equity 2023: € -6,196 ▼ € 8,650 vs 2022 (€ 2,454) Unfavourable step	€ -16,570 Equity 2024: € -16,570 ▼ € 10,374 vs 2023 (€ -6,196) Unfavourable step	▼ € 10,374
Total debts	€ 292,458 Total debts 2021: € 292,458 First fiscal year in the series	€ 255,534 Total debts 2022: € 255,534 ▼ 13% vs 2021 (€ 292,458) Favourable step	€ 221,431 Total debts 2023: € 221,431 ▼ 13% vs 2022 (€ 255,534) Favourable step	€ 225,506 Total debts 2024: € 225,506 ▲ 2% vs 2023 (€ 221,431) Unfavourable step	▲ 2%
Cash	€ 1,493 Cash 2021: € 1,493 First fiscal year in the series	-	€ 431 Cash 2023: € 431 First fiscal year in the series	€ 594 Cash 2024: € 594 ▲ 38% vs 2023 (€ 431) Favourable step	▲ 38%
Retained profit	€ -25,652 Retained profit 2021: € -25,652 First fiscal year in the series	€ -3,546 Retained profit 2022: € -3,546 ▲ € 22,107 vs 2021 (€ -25,652) Favourable step	€ -12,196 Retained profit 2023: € -12,196 ▼ € 8,650 vs 2022 (€ -3,546) Unfavourable step	€ -22,570 Retained profit 2024: € -22,570 ▼ € 10,374 vs 2023 (€ -12,196) Unfavourable step	▼ € 10,374
Bank debt	€ 193,240 Bank debt 2021: € 193,240 First fiscal year in the series	€ 172,678 Bank debt 2022: € 172,678 ▼ 11% vs 2021 (€ 193,240) Favourable step	€ 208,206 Bank debt 2023: € 208,206 ▲ 21% vs 2022 (€ 172,678) Unfavourable step	€ 176,526 Bank debt 2024: € 176,526 ▼ 15% vs 2023 (€ 208,206) Favourable step	▼ 15%
Balance sheet total	€ 272,806 Balance sheet total 2021: € 272,806 First fiscal year in the series	€ 257,988 Balance sheet total 2022: € 257,988 ▼ 5% vs 2021 (€ 272,806) Unchanged	€ 215,235 Balance sheet total 2023: € 215,235 ▼ 17% vs 2022 (€ 257,988) Unchanged	€ 208,936 Balance sheet total 2024: € 208,936 ▼ 3% vs 2023 (€ 215,235) Unchanged	▼ 3%

Key figures of SB MEDICAL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to SB MEDICAL?

What happened at SB MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Nov 14, 2025 New annual accounts for financial year 2024: loss of € 10,374. filed late Source: NBB ↗
Jul 1, 2021 New establishment in Wezembeek-Oppem. KBO
Jun 23, 2020 New establishment in Brussel. KBO
Jun 23, 2020 Start of the company according to the CBE. KBO
2020 SHAKE BAKHSHYAN became a director. NBB

In short

From € 25,652 loss in 2021 to € 10,374 loss in 2024.

Paid € 4,546 in corporate taxes since 2021.

Best year ever: 2022, with € 22,107 profit.

Original PDFs at the National Bank ↗

A new publication or filing at SB MEDICAL? We notify you, reason included.

Follow SB MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SHAKE BAKHSHYAN

SB MEDICAL

EUROCARE MEDICAL

Behind SB MEDICAL is SHAKE BAKHSHYAN. SHAKE BAKHSHYAN is also behind EUROCARE MEDICAL.

See the full network in the app

Directors

According to the 2024 annual accounts

SHAKE BAKHSHYAN

Director

Also active at: EUROCARE MEDICAL

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Jacques de Lalaingstraat 18

1040 Brussel

2.328.016.430

Warandeberg 94

1970 Wezembeek-Oppem

Active since 1 July 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0748.860.883
VAT number: BE 0748.860.883
Registered office: Jacques de Lalaingstraat 18, 1040 Brussel
Names & denominations: SB MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 June 2020
Peppol: Active · Active since 6 Jan 2026
Contact: [email protected] +32486020203
Activities · NACE: Huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗